Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
- Status
- COMPLETED
- Phase
- PHASE3
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population
- Status
- UNKNOWN
- Phase
- PHASE4
SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors
- Status
- COMPLETED
- Phase
- PHASE4
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus in Treating Cutaneous T-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.
- Status
- COMPLETED
- Phase
- NA
The Everolimus-Transplant Exit Strategy Trial (E-TEST)
- Status
- TERMINATED
- Phase
- PHASE3
Renal Transplantation in the Elderly - nEverOld Study
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2